Drug Discoveries & Therapeutics
Online ISSN : 1881-784X
Print ISSN : 1881-7831
ISSN-L : 1881-7831
Review
Regulation of food intake and the development of anti-obesity drugs
Yue Chen
Author information
JOURNALS FREE ACCESS

2016 Volume 10 Issue 2 Pages 62-73

Details
Abstract

As the most significant cause of death worldwide, obesity has become one of the world's most important public health problems, but approved anti-obesity drugs are extremely limited. This article summarizes the feeding control circuits and regulators involved in obesity development, highlight the hypothalamus, melanocortin system and brain-gut peptide actions in this process, and the five US FDA approved anti-obesity medications in long term use, namely phentermine/topiramate, lorcaserin, naltrexone/bupropion, liraglutide and orlistat.

Information related to the author
© 2016 International Research and Cooperation Association for Bio & Socio-Sciences Advancement
Next article
feedback
Top